Correction: Opiant Pharmaceuticals, Inc. (“Opiant” or “Company”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines to treat addictions and drug overdose, reports that the company mistakenly reissued the press release this afternoon entitled, "Opiant Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)." This press release is a duplicate of the press release issued on December 20, 2021. The company regrets the error.

For Media and Investor Inquiries:Ben Atkins, Opiant(310) 598-5410batkins@opiant.com

 

Opiant Pharmaceuticals (NASDAQ:OPNT)
Historical Stock Chart
From Jun 2022 to Jul 2022 Click Here for more Opiant Pharmaceuticals Charts.
Opiant Pharmaceuticals (NASDAQ:OPNT)
Historical Stock Chart
From Jul 2021 to Jul 2022 Click Here for more Opiant Pharmaceuticals Charts.